Sustained virologic response to standard interferon or pegylated interferon and ribavirin in patients with hepatitis C virus genotype 5: systematic review and meta-analysis of ten studies and 423 patients-Reference-Cited by-同舟云学术

Sustained virologic response to standard interferon or pegylated interferon and ribavirin in patients with hepatitis C virus genotype 5: systematic review and meta-analysis of ten studies and 423 patients

Published:2015-05-28 Issue:3 Volume:9 Page:431-437
ISSN:1936-0533
Container-title:Hepatology International
language:en
Short-container-title:Hepatol Int

Author:

Devaki Pardha,Jencks David,Yee Brittany E.,Nguyen Mindie H.

Publisher

Springer Science and Business Media LLC

Subject

Hepatology

Link

http://link.springer.com/content/pdf/10.1007/s12072-015-9635-z.pdf

Reference20 articles.

1. WHO. Hepatitis C: Media Centre. World Health Organization. http://www.who.int/mediacentre/factsheets/fs164/en/ . 28 Aug 2014

2. Francisco MAN, Holtzman D. Global burden of hepatitis C: considerations for healthcare providers in the United States. Clin Infect Dis 2012;55(S1):S10–S15

3. Papastergious VSL, Lisgos P, et al. Hepatitis C virus genotype 5: prospective evaluation of peginterferon/ribavirin treatment efficacy and predictive value of on-treatment virological responses for sustained virological response. Clin Gastroenterol 2014;48(2):160–165

4. Smuts HEKJ. Genotyping of hepatitis C virus in South Africa. J Clin Microbiol 1995;33:1679–1681

5. Wantuck JMAA, Nguyen MH. Review article: the epidemiology and therapy of chronic hepatitis C genotypes 4, 5 and 6. Aliment Pharmacol Ther 2014;39(2):137–147

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Eliminating hepatitis C within low-income countries – The need to cure genotypes 4, 5, 6;Journal of Hepatology;2018-04

2. Personalized Medicine for Hepatitis C Virus;Diagnostic Molecular Pathology;2017

3. Effects of Cirrhosis on Short-term and Long-term Survival of Patients With Hepatitis B–related Hepatocellular Carcinoma;Clinical Gastroenterology and Hepatology;2016-06

4. Ledipasvir-sofosbuvir in patients with hepatitis C virus genotype 5 infection: an open-label, multicentre, single-arm, phase 2 study;The Lancet Infectious Diseases;2016-04

5. Sustained virological response with sofosbuvir and ledipasvir for hepatitis C virus genotype 5;The Lancet Infectious Diseases;2016-04